Joseph Kleiman examines how Trump Rx could pressure pharmacy benefit managers and retailers to increase transparency and affordability, while cautioning that its long-term impact will depend on price consistency.
Joseph Kleiman
Advertisement
Drawing from his work across prescription pricing and fulfillment infrastructure, Kleinman can offer insight into how alternative pricing models interact with prescribing workflows, coverage rules, and pharmacy operations, and why backend execution ultimately determines whether transparency goals are achieved
Articles by Joseph Kleiman
Buzz Health President Joseph Kleiman discusses how TrumpRx is reshaping drug price transparency, highlighting the benefits of early price visibility for consumers alongside the operational challenges of fluctuating costs, consistency and potential.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
2
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
3
How Are Automation and AI Impacting the Timeline From Prescription to Starting Treatment?
4
U.S. Measles Outbreak Highlights Growing Vaccine Hesitancy: Q&A With Jeanne Marrazzo
5